Hormonal development therapy (HDT) in hypogonadism in long-term view

References 

1. Heinz M. Hormonelle Entwicklungstherapie bei Adoleszentinnen. korasion. 2006;1:1–2www.kindergynaekologie.de
2. Ranke MB, Dörr HG. Hypogonadismus in der Adoleszenz. Verlag Wissenschaftliche Scripten Zwickau. www.kindergyaekologie.de2008;
3. Ranke MB. Dörr HG Ersatztherapie mit Sexualsteroiden in der Adoleszenz bei Hypogonadismus Konsensus eines Expertenworkshops. Gyn.Endocrinol. 2009; 7:111-18 Monatsschr.Kinderheilk. 2009;157(3):260–266www.springerlink.com/content/
4. Illig R. A physiological mode of puberty induction in hypogonadal girls with low dose transdermal 17-Beta-estradiol. Eur J Pediatr. 1990;150:86–91
   • MEDLINE
   • CrossRef
5. Gussinye M, Terrades P, Yeste D, et al. Low areal bone mineral density values in adolescents and young adult Turner syndrome patients increase after long-term transdermal estradiol therapy. Horm.Res. 2000;54(3):131–135
6. Carrascosa A, Gussinye M, Terradas P, et al. Spontaneous, but not induced puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res. 2000;15(10):2005-10
7. Ankerberg-Lindgren C, Elfving M, Albertsson Wikland K, et al. Nocturnal application of transdermal estradiol patches produce levels of estradiol that mimic those seen at the onset spontaneous puberty. J Clin Endocrinol Metab. 2001;86:3039–3044
   • MEDLINE
   • CrossRef
8. Piippo S, Lenko H, Kainulainen P, et al. Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab. 2004;89:3241–3247
   • MEDLINE
   • CrossRef
9. Klibanski A, Biller BM, Schoenfeld A, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995;80(3):898–904
   • MEDLINE
   • CrossRef
10. Munoz MT. Argente J Anorexia nervosa: Hypogonadotrophic Hypogonadismus and Bone Mineral Density. Horm Res. 2002;57(Suppl 2):57–62
    • MEDLINE
    • CrossRef
11. Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab. 2007;92(1):10–25
    • MEDLINE
12. Heinz M. Hormontherapie bei Hypogonadismus in Pubertät und Adoleszenz. Wann sind Kontrazeptiva indiziert?. Korasion. 2009;1:1–3www.kindergynaekologie.de
13. Campagnoli C, Ambroggio S, Beforte P, et al. The long-term estrogen progestin Therapy in subjects with hypergonadotropic states. In:  Bruni V,  Dei M editor. Pediatric and Adolescent Gynecology. Rome: CIC Edizioni Internazionali; 2003;p. 522–530
14. Lanes R, Gunczler P, Esaa S, et al. Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density. Fertl Steril. 1999;72(5):896–899
15. Bondy CA, Ceniceros I, Lange E, et al. Declining estrogen use in young women with Turner syndrome. Arch Intern Med. 2006;166(12):1322
    • MEDLINE
    • CrossRef